JANE STREET GROUP, LLC - CLEARSIDE BIOMEDICAL INC ownership

CLEARSIDE BIOMEDICAL INC's ticker is CLSD and the CUSIP is 185063104. A total of 69 filers reported holding CLEARSIDE BIOMEDICAL INC in Q3 2021. The put-call ratio across all filers is 0.93 and the average weighting 0.2%.

Quarter-by-quarter ownership
JANE STREET GROUP, LLC ownership history of CLEARSIDE BIOMEDICAL INC
ValueSharesWeighting
Q2 2023$17,860
+12.0%
15,946
+12.0%
0.00%
Q4 2022$15,940
-91.9%
14,232
-83.5%
0.00%
Q1 2022$197,000
+245.6%
86,216
+314.7%
0.00%
Q4 2021$57,000
-61.7%
20,792
-16.2%
0.00%
Q3 2021$149,000
+43.3%
24,800
-55.2%
0.00%
Q2 2020$104,000
+48.6%
55,348
+33.8%
0.00%
Q1 2020$70,000
-28.6%
41,366
-58.9%
0.00%
Q2 2019$98,000100,5340.00%
Other shareholders
CLEARSIDE BIOMEDICAL INC shareholders Q3 2021
NameSharesValueWeighting ↓
ACT CAPITAL MANAGEMENT, LLC 2,467,500$14,805,0007.67%
ACUTA CAPITAL PARTNERS, LLC 1,316,268$7,898,0002.79%
AJU IB Investment Co., Ltd. 293,555$1,761,0001.14%
RTW INVESTMENTS, LP 4,206,765$25,241,0000.38%
EAM Investors, LLC 247,561$1,485,0000.25%
Carmignac Gestion 2,475,652$14,854,0000.18%
Curi Wealth Management, LLC 25,000$150,0000.07%
CAXTON ASSOCIATES LP 66,569$399,0000.04%
Newman Dignan & Sheerar, Inc. 21,523$129,0000.04%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 316,600$1,900,0000.04%
View complete list of CLEARSIDE BIOMEDICAL INC shareholders